Publication:
The Utility of CRISPR/Cas9 Technology to Attenuate Apoptotic Pressure in Monoclonal Antibody (mAb) Producing Cells

Placeholder

Organizational Units

Program

Authors

Doymaz M. Z.
Aydın B. N.
Çetin N. S.
Kaygusuz A.

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Description

Source:

Keywords:

Citation

Doymaz M. Z., Aydın B. N., Çetin N. S., Kaygusuz A., \"The Utility of CRISPR/Cas9 Technology to Attenuate Apoptotic Pressure in Monoclonal Antibody (mAb) Producing Cells\", 5th International Molecular Immunology & Immunogenetics Congress (MIMIC-V) Scientific Programme, İzmir, Türkiye, 20 - 22 Ekim 2022, ss.38

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads


Sustainable Development Goals